Cancer Network
CONTINUE TO SITE

OR WAIT null SECS

Cancer Network
Spotlight
Expert on Rechallenging With Rituximab and Second-Line Therapies for R/R DLBCLManagement of Transplant-Ineligible Multiple MyelomaRegister: Advances in the Treatment of MyelofibrosisRegister: Improving Outcomes in Advanced Prostate CancerRegister: The Evolving HER2+ Metastatic Breast Cancer Treatment LandscapeTaking a Patient-First Approach to Treatment in CLLUpdates in Therapies of Relapsed and Refractory Follicular Lymphoma
Clinical
View MoreBrain CancerBreast CancerColorectal CancerGastrointestinal CancerGenitourinary CancerGynecologic CancerHematologyLeukemiaLung CancerLymphomaPediatric CancersSkin Cancer
News
Clinical TopicsIntegrative CareAll News
Media
Around the PracticeBetween the LinesClinical ConsultExpert InterviewsMedical World NewsOncViewPodcastsReadout 360
Conferences
Publications
All JournalsFor AuthorsTumor Board
CME/CE
Resources
Contemporary ConceptsNurse Practitioners/Physician's AssistantsPartnersSponsored
Subscribe
eNewsletterPrint Subscription

  • CureToday.com
  • OncLive.com
  • TargetedOnc.com
  • Contact
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Information
  • MJHLS Brand Logo

© 2021 MJH Life Sciences and Cancer Network. All rights reserved.

Spotlight
  • Expert on Rechallenging With Rituximab and Second-Line Therapies for R/R DLBCL
  • Management of Transplant-Ineligible Multiple Myeloma
  • Register: Advances in the Treatment of Myelofibrosis
  • Register: Improving Outcomes in Advanced Prostate Cancer
  • Register: The Evolving HER2+ Metastatic Breast Cancer Treatment Landscape
  • Taking a Patient-First Approach to Treatment in CLL
  • Updates in Therapies of Relapsed and Refractory Follicular Lymphoma
ClinicalSee All >
  • Brain Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Gastrointestinal Cancer
  • Genitourinary Cancer
  • Gynecologic Cancer
  • Hematology
  • Leukemia
  • Lung Cancer
  • Lymphoma
  • Pediatric Cancers
  • Skin Cancer
  • CureToday.com
  • OncLive.com
  • TargetedOnc.com
  • Contact
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Information
  • MJHLS Brand Logo

© 2021 MJH Life Sciences™ and Cancer Network. All rights reserved.

Survivorship incorporated into primary cancer care may be more cost effective and lead to better clinical and patient-reported outcomes in patients with breast cancer and other malignancies.

View Article

Behavioral interventions were found to help young breast cancer survivors in reducing their depressive symptoms.

View Article

A survey of breast cancer survivors in the US showed that “patients were universally affected by COVID in terms of delays in breast cancer care.”

View Article